The overlap between the gene set enrichment of EDA‐A2‐treated myotubes and type IIb myonuclei argues that EDA2R upregulation in the cachectic myonuclei likely contributes to the transcriptional reprogramming taking place after tumour inoculation. Here, EDA2R is linked to neoplasm.